Loading...
•
Jun 30, 2022
Hims & Hers Q2 2022 Earnings Report
Reported outstanding Q2 2022 results driven by consumer-centric strategy and platform demand.
Key Takeaways
Hims & Hers Health, Inc. reported an 87% increase in quarterly revenue, reaching $113.6 million in Q2 2022. The company saw record growth in net new subscriptions for the second straight quarter, ending with 817,000 subscriptions. Due to this momentum, the company raised its full year 2022 revenue guidance to $470 million to $485 million and Adjusted EBITDA guidance to $(27) million to $(20) million.
Revenue was $113.6 million for the second quarter 2022, an increase of 87% year-over-year.
Net loss was $(19.7) million for the second quarter 2022.
Gross margin was 77% for the second quarter 2022.
Ended Q2 2022 with 817,000 subscriptions, up 80% year-over-year.
Revenue by Segment
Forward Guidance
Hims & Hers provides guidance based on current market conditions and expectations for revenue and Adjusted EBITDA. For the full year 2022, we expect revenue to be in the range of $470 million to $485 million and Adjusted EBITDA to be in the range of $(27) million to $(20) million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...